These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29281266)

  • 1. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity.
    Narwal M; Jemth AS; Gustafsson R; Almlöf I; Warpman Berglund U; Helleday T; Stenmark P
    Biochemistry; 2018 Feb; 57(5):593-603. PubMed ID: 29281266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of human MTH1 and the 8-oxo-dGMP product complex.
    Svensson LM; Jemth AS; Desroses M; Loseva O; Helleday T; Högbom M; Stenmark P
    FEBS Lett; 2011 Aug; 585(16):2617-21. PubMed ID: 21787772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure of human MTH1, a Nudix family hydrolase that selectively degrades oxidized purine nucleoside triphosphates.
    Mishima M; Sakai Y; Itoh N; Kamiya H; Furuichi M; Takahashi M; Yamagata Y; Iwai S; Nakabeppu Y; Shirakawa M
    J Biol Chem; 2004 Aug; 279(32):33806-15. PubMed ID: 15133035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool.
    Gad H; Koolmeister T; Jemth AS; Eshtad S; Jacques SA; Ström CE; Svensson LM; Schultz N; Lundbäck T; Einarsdottir BO; Saleh A; Göktürk C; Baranczewski P; Svensson R; Berntsson RP; Gustafsson R; Strömberg K; Sanjiv K; Jacques-Cordonnier MC; Desroses M; Gustavsson AL; Olofsson R; Johansson F; Homan EJ; Loseva O; Bräutigam L; Johansson L; Höglund A; Hagenkort A; Pham T; Altun M; Gaugaz FZ; Vikingsson S; Evers B; Henriksson M; Vallin KS; Wallner OA; Hammarström LG; Wiita E; Almlöf I; Kalderén C; Axelsson H; Djureinovic T; Puigvert JC; Häggblad M; Jeppsson F; Martens U; Lundin C; Lundgren B; Granelli I; Jensen AJ; Artursson P; Nilsson JA; Stenmark P; Scobie M; Berglund UW; Helleday T
    Nature; 2014 Apr; 508(7495):215-21. PubMed ID: 24695224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A molecular basis for the selective recognition of 2-hydroxy-dATP and 8-oxo-dGTP by human MTH1.
    Sakai Y; Furuichi M; Takahashi M; Mishima M; Iwai S; Shirakawa M; Nakabeppu Y
    J Biol Chem; 2002 Mar; 277(10):8579-87. PubMed ID: 11756418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MutT homologue 1 (MTH1) catalyzes the hydrolysis of mutagenic O6-methyl-dGTP.
    Jemth AS; Gustafsson R; Bräutigam L; Henriksson L; Vallin KSA; Sarno A; Almlöf I; Homan E; Rasti A; Warpman Berglund U; Stenmark P; Helleday T
    Nucleic Acids Res; 2018 Nov; 46(20):10888-10904. PubMed ID: 30304478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The presumed MTH1-inhibitor TH588 sensitizes colorectal carcinoma cells to ionizing radiation in hypoxia.
    Pompsch M; Vogel J; Classen F; Kranz P; Iliakis G; Riffkin H; Brockmeier U; Metzen E
    BMC Cancer; 2018 Nov; 18(1):1190. PubMed ID: 30497423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of residue in the position of 116 on the inhibitory potency of TH588 for MTH1.
    Niu RJ; Zheng QC; Zhang HX
    J Mol Graph Model; 2018 Oct; 85():75-83. PubMed ID: 30103119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of MTH1-Binding Nucleotide Analogs Based on 7,8-Dihalogenated 7-Deaza-dG Derivatives.
    Shi H; Ishikawa R; Heh CH; Sasaki S; Taniguchi Y
    Int J Mol Sci; 2021 Jan; 22(3):. PubMed ID: 33525366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTH1 Substrate Recognition--An Example of Specific Promiscuity.
    Nissink JW; Bista M; Breed J; Carter N; Embrey K; Read J; Winter-Holt JJ
    PLoS One; 2016; 11(3):e0151154. PubMed ID: 26999531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crystal structure, biochemical and cellular activities demonstrate separate functions of MTH1 and MTH2.
    Carter M; Jemth AS; Hagenkort A; Page BD; Gustafsson R; Griese JJ; Gad H; Valerie NC; Desroses M; Boström J; Warpman Berglund U; Helleday T; Stenmark P
    Nat Commun; 2015 Aug; 6():7871. PubMed ID: 26238318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of nucleotide analogs containing the 7,8-dihydro-8-oxo structure by the human MTH1 protein.
    Kamiya H; Cadena-Amaro C; Dugué L; Yakushiji H; Minakawa N; Matsuda A; Pochet S; Nakabeppu Y; Harashima H
    J Biochem; 2006 Dec; 140(6):843-9. PubMed ID: 17071637
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation and development of MTH1 inhibitors for treatment of cancer.
    Warpman Berglund U; Sanjiv K; Gad H; Kalderén C; Koolmeister T; Pham T; Gokturk C; Jafari R; Maddalo G; Seashore-Ludlow B; Chernobrovkin A; Manoilov A; Pateras IS; Rasti A; Jemth AS; Almlöf I; Loseva O; Visnes T; Einarsdottir BO; Gaugaz FZ; Saleh A; Platzack B; Wallner OA; Vallin KS; Henriksson M; Wakchaure P; Borhade S; Herr P; Kallberg Y; Baranczewski P; Homan EJ; Wiita E; Nagpal V; Meijer T; Schipper N; Rudd SG; Bräutigam L; Lindqvist A; Filppula A; Lee TC; Artursson P; Nilsson JA; Gorgoulis VG; Lehtiö J; Zubarev RA; Scobie M; Helleday T
    Ann Oncol; 2016 Dec; 27(12):2275-2283. PubMed ID: 27827301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse MTH1 protein with 8-oxo-7,8-dihydro-2'-deoxyguanosine 5'-triphosphatase activity that prevents transversion mutation. cDNA cloning and tissue distribution.
    Kakuma T; Nishida J; Tsuzuki T; Sekiguchi M
    J Biol Chem; 1995 Oct; 270(43):25942-8. PubMed ID: 7592783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of a new class of MTH1 inhibitor by X-ray crystallographic screening.
    Yokoyama T; Kitakami R; Mizuguchi M
    Eur J Med Chem; 2019 Apr; 167():153-160. PubMed ID: 30771603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of tryptophan residues in the recognition of mutagenic oxidized nucleotides by human antimutator MTH1 protein.
    Takahashi M; Maraboeuf F; Sakai Y; Yakushiji H; Mishima M; Shirakawa M; Iwai S; Hayakawa H; Sekiguchi M; Nakabeppu Y
    J Mol Biol; 2002 May; 319(1):129-39. PubMed ID: 12051941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavity.
    Peng C; Li YH; Yu CW; Cheng ZH; Liu JR; Hsu JL; Hsin LW; Huang CT; Juan HF; Chern JW; Cheng YS
    Bioorg Chem; 2021 May; 110():104813. PubMed ID: 33774493
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and Kinetic Studies of the Human Nudix Hydrolase MTH1 Reveal the Mechanism for Its Broad Substrate Specificity.
    Waz S; Nakamura T; Hirata K; Koga-Ogawa Y; Chirifu M; Arimori T; Tamada T; Ikemizu S; Nakabeppu Y; Yamagata Y
    J Biol Chem; 2017 Feb; 292(7):2785-2794. PubMed ID: 28035004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MutT homologue 1 (MTH1) removes N6-methyl-dATP from the dNTP pool.
    Scaletti ER; Vallin KS; Bräutigam L; Sarno A; Warpman Berglund U; Helleday T; Stenmark P; Jemth AS
    J Biol Chem; 2020 Apr; 295(15):4761-4772. PubMed ID: 32144205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TH588, an MTH1 inhibitor, enhances phenethyl isothiocyanate-induced growth inhibition in pancreatic cancer cells.
    Ikejiri F; Honma Y; Kasukabe T; Urano T; Suzumiya J
    Oncol Lett; 2018 Mar; 15(3):3240-3244. PubMed ID: 29435064
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.